ANTIBODIES

Contributor Information
- Institute Yale University
Tool Details
- Tool name: Anti-CD3 [500.A2]
- Tool type: Antibodies
- Tool sub-type: Primary Antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Host: Hamster
- Cancer type: Head and neck cancer
- Description: Monoclonal antibody capable of activating T cells and cloned T cell lines. Background and Research Application The CD3 complex, composed of four distinct CD3 polypeptide chains (CD3?, CD3? and 2X CD3?), associates with the T cell antigen receptor (TCR. CD3 is a member of the immunoglobulin superfamily, involved in antigen recognition, T lymphocyte activation and signal transduction. CD3 may play a role in TCR-induced growth arrest, cell survival and proliferation. The CD3 antigen is present on 68-82% of normal peripheral blood lymphocytes, 65-85% of thymocytes and Purkinje cells in the cerebellum. It is never expressed on B or NK cells. Decreased percentages of T lymphocytes may be observed in some autoimmune diseases. This antibody activates cloned T cell lines and normal T cells, provided suitable accessory cells and signals are present. Binding of anti-CD3 (500.A2) to CD3 initiates the intracellular biochemical pathway resulting in cellular activation and proliferation.
- Immunogen: 25-kDa e chain of the T-cell receptor-associated CD3 complex
- Immunogen UniProt ID: A0A3Q0CNZ4
- Isotype: IgG
- Research area: Immunology
- For Research Use Only
Target Details
- Target: CD3
- Target background: Monoclonal antibody capable of activating T cells and cloned T cell lines. Background and Research Application The CD3 complex, composed of four distinct CD3 polypeptide chains (CD3?, CD3d and 2X CD3), associates with the T cell antigen receptor (TCR. CD3 is a member of the immunoglobulin superfamily, involved in antigen recognition, T lymphocyte activation and signal transduction. CD3 may play a role in TCR-induced growth arrest, cell survival and proliferation. The CD3 antigen is present on 68-82% of normal peripheral blood lymphocytes, 65-85% of thymocytes and Purkinje cells in the cerebellum. It is never expressed on B or NK cells. Decreased percentages of T lymphocytes may be observed in some autoimmune diseases. This antibody activates cloned T cell lines and normal T cells, provided suitable accessory cells and signals are present. Binding of anti-CD3 (500.A2) to CD3 initiates the intracellular biochemical pathway resulting in cellular activation and proliferation.
Application Details
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: Store at -20ðC frozen. Avoid repeated freeze / thaw cycles
- Shipping conditions: Shipping at 4ðC
Related Tools
References
- • Chen et al. 2019. JCI Insight. 4(22):. PMID: 31723059.
- • Trittel et al. 2019. Sci Rep. 9(1):16362. PMID: 31704965.
- • Czarnewski et al. 2019. Nat Commun. 10(1):2892. PMID: 31253778.
- • Zwick et al. 2019. Front Immunol. 10:222. PMID: 30809231.
- • Shahbaz et al. 2018. PLoS Biol. 16(12):e2006649. PMID: 30550561.
- • Maj et al. 2017. Nat Immunol. 18(12):1332-1341. PMID: 29083399.
- • Long et al. 2016. Genes (Basel). 8(1):. PMID: 28035981.
- • Portoles et al. 1989. J Immunol. 142(12):4169-75. PMID: 2470817.